Department of Rehabilitation, Orthopaedic Surgery, Psoriasis Center, Nippon Life Hospital, Osaka, Japan.
Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
Mod Rheumatol. 2024 Aug 20;34(5):1076-1078. doi: 10.1093/mr/roae003.
The concept of pustulotic arthro-osteitis (PAO) was first reported by Sonozaki et al. in 1979, with diagnostic criteria (Sonozaki criteria) proposed in 1981. These criteria have served as the gold standard for PAO diagnosis for over 40 years. In recent years, there has been an increasing emphasis on maximizing the quality of life of patients with PAO. This is achieved by striving for clinical remission, structural remission, and functional remission through early diagnosis and appropriate therapeutic intervention from an early stage. This article is an English translation of a summary of the 'Modified PAO Diagnostic Guidance 2022', edited by the Japan Ministry of Health, Labour and Welfare's Research Group on improvement of medical standard and quality of life of patients with spondyloarthritis and related diseases represented by ankylosing spondylitis and the Japan Spondyloarthritis Society. This guidance is intended to be helpful to both Japanese and global communities in rheumatology and spondyloarthritis.
脓疱性关节炎-骨炎（PAO）的概念最早由 Sonozaki 等人于 1979 年报道，1981 年提出了诊断标准（Sonozaki 标准）。这些标准作为 PAO 诊断的金标准已经超过 40 年。近年来，人们越来越重视提高 PAO 患者的生活质量。这可以通过早期诊断和早期适当的治疗干预来实现临床缓解、结构缓解和功能缓解。本文是由日本厚生劳动省的研究小组编辑的“改良 PAO 诊断指南 2022”的英文摘要翻译，该研究小组由代表强直性脊柱炎的脊柱关节炎和相关疾病的改善医学标准和患者生活质量的日本脊柱炎协会组成。本指南旨在为日本和全球的风湿病学和脊柱关节炎领域提供帮助。
